Showing results (21-30 of 86) with videos related to
Sort By:
Pageof 9
Cancers|October 28, 2023
Immunotherapy with Monoclonal Antibodies for Acute Myeloid Leukemia: A Work in ProgressMatteo Molica, Salvatore Perrone, Costanza Andriola, et al.Cancer Drug Resistance (Alhambra, Calif.)|July 17, 2023
How acute myeloid leukemia (AML) escapes from FMS-related tyrosine kinase 3 (FLT3) inhibitors? Still an overrated complication?Salvatore Perrone, Tiziana Ottone, Nadezda Zhdanovskaya, et al.Cancers|November 13, 2025
The Silent Revolution of the Genome: The Role of Optical Genome Mapping in Acute Lymphoblastic LeukemiaClaudia Simio, Matteo Molica, Laura De Fazio, et al.Cancer|March 31, 2026
Hypomethylating agents plus venetoclax in younger acute myeloid leukemia: Meta-analysis of a shifting treatment paradigmSalvatore Perrone, Laura De Fazio, Sebastian Monachetti, et al.Leukemia & Lymphoma|April 15, 2026
Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitorsLaura De Fazio, Matteo Molica, Claudia Simio, et al.International Journal of Molecular Sciences|April 14, 2026
Multi-Omics Applications in Adult Acute Lymphoblastic Leukemia: From Biological Mechanisms to Precision TherapiesClaudia Simio, Matteo Molica, Laura De Fazio, et al.Frontiers in Oncology|February 25, 2021
TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?Matteo Molica, Carla Mazzone, Pasquale Niscola, et al.Current Oncology (Toronto, Ont.)|October 25, 2024
Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid LeukemiaMartina Canichella, Matteo Molica, Carla Mazzone, et al.Cancers|January 11, 2024
Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent AdvancesMartina Canichella, Matteo Molica, Carla Mazzone, et al.Therapeutic Advances in Hematology|March 12, 2019
Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemiaMatteo Molica, Emilia Scalzulli, Gioia Colafigli, et al.Pageof 9